Source Post

Down 32% in 2026, Is Symbotic Stock a Buy? | SYM Stock Analysis

Symbiotic reported strong revenue growth of 22% year-over-year, reaching $721 million, and holds a substantial $22.5 billion backlog. The company faces execution challenges in delivering its complex warehouse automation solutions quickly. Despite a recent share price decline, the stock is trading at historically low valuation multiples, presenting a potential buying opportunity. The creator updated their DCF model, decreasing free cash flow estimates but lowering the company's risk profile due to improved profitability and a stronger market position.

Linked Mentions

Tickers discussed in this post

WMTNeutralLow ConvictionResearch Only

Walmart is highlighted for its e-commerce improvements and its strategic relationship with Symbiotic, though it trades at a more expensive valuation than Amazon.

AMZNNeutralLow ConvictionResearch Only

Amazon is mentioned as a benchmark for Walmart's e-commerce growth, with Walmart trading at a more expensive valuation.

SYMBullishMedium ConvictionSignal-backedPrimary

Symbiotic's stock is down 32% in 2026, trading at near multi-year lows, making it a potential buying opportunity.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.